• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续性嗅觉功能障碍作为新冠后综合征认知障碍的指标:对监测和康复的启示

Persistent olfactory dysfunction as an indicator of cognitive impairment in long COVID-19 syndrome: implications for monitoring and rehabilitation.

作者信息

Paranhos Alna Carolina Mendes, Dias Apio Ricardo Nazareth, Mendes Erick Antonio Rodrigues, Paixão Emily Vitória Almeida, Silva Samuel Franco Viana Santos, Dos Santos Lidiane Palheta Miranda, Koury Gisele Vieira Hennemann, Domingues Mariângela Moreno, Quaresma Juarez Antônio Simões, da Silva Souza Givago, Falcão Luiz Fábio Magno

机构信息

Centro de Ciências Biológicas e da Saúde, Universidade do Estado do Pará, Trav. Perebebui, 2623, Belém, PA, 66023-000, Brazil.

Núcleo de Medicina Tropical, Universidade Federal do Pará, Av. Generalissimo Deodoro, 92, Belém, Pará, 66055-240, Brazil.

出版信息

Eur Arch Psychiatry Clin Neurosci. 2025 Sep 12. doi: 10.1007/s00406-025-02116-7.

DOI:10.1007/s00406-025-02116-7
PMID:40938404
Abstract

BACKGROUND

Persistent olfactory dysfunction (OD) and cognitive impairment are among the most frequently reported sequelae of long term infection with SARS-CoV-2 (long COVID-19). However, the association between these conditions remains unclear. This study investigated the correlation between OD and cognitive impairment in patients recovering from COVID-19 to identify the implications for therapeutic and rehabilitation strategies.

MATERIALS AND METHODS

A cross-sectional study of adult patients diagnosed with long COVID was conducted at a healthcare centre in Brazil. Olfactory function was assessed using the Connecticut Chemosensory Clinical Research Centre (CCCRC) test, and cognitive performance was evaluated using the Montreal Cognitive Assessment (MoCA). Statistical analyses included odds ratios (OR) and linear regression to explore the association between OD severity and cognitive scores, adjusting for potential confounders such as age, sex, and comorbidities.

RESULTS

A total of 241 patients (age: 48.60 ± 12.68 years; 73% female) were included. Cognitive impairment (MoCA < 23) was present in 64% of the participants. OD was identified in 92% of the patients and ranged from mild to anosmia. Linear regression analysis showed a weak yet statistically significant correlation between the CCCRC and MoCA scores (R = 0.14, p = 0.02). An OR of 2.87 (95% CI: 1.57-5.25, p = 0.00) indicated higher odds of cognitive impairment in patients with severe OD.

DISCUSSION

This study supports the hypothesis that there is a weak yet significant association between OD and cognitive impairment in patients with long COVID. These findings underscore the importance of early screening for olfactory dysfunction as a potential marker of cognitive monitoring and the need for intervention in this population.

摘要

背景

持续性嗅觉功能障碍(OD)和认知障碍是严重急性呼吸综合征冠状病毒2(SARS-CoV-2)长期感染(长程新冠肺炎)最常报告的后遗症。然而,这些情况之间的关联仍不清楚。本研究调查了新冠肺炎康复患者中OD与认知障碍之间的相关性,以确定其对治疗和康复策略的影响。

材料与方法

在巴西的一个医疗中心对诊断为长程新冠肺炎的成年患者进行了一项横断面研究。使用康涅狄格化学感觉临床研究中心(CCCRC)测试评估嗅觉功能,使用蒙特利尔认知评估量表(MoCA)评估认知表现。统计分析包括比值比(OR)和线性回归,以探讨OD严重程度与认知分数之间的关联,并对年龄、性别和合并症等潜在混杂因素进行校正。

结果

共纳入241例患者(年龄:48.60±12.68岁;73%为女性)。64%的参与者存在认知障碍(MoCA<23)。92%的患者被诊断为OD,程度从轻度到嗅觉丧失不等。线性回归分析显示CCCRC和MoCA分数之间存在微弱但具有统计学意义的相关性(R=0.14,p=0.02)。OR为2.87(95%CI:1.57-5.25,p=0.00)表明严重OD患者发生认知障碍的几率更高。

讨论

本研究支持以下假设,即长程新冠肺炎患者的OD与认知障碍之间存在微弱但显著的关联。这些发现强调了早期筛查嗅觉功能障碍作为认知监测潜在标志物的重要性,以及对该人群进行干预的必要性。

相似文献

1
Persistent olfactory dysfunction as an indicator of cognitive impairment in long COVID-19 syndrome: implications for monitoring and rehabilitation.持续性嗅觉功能障碍作为新冠后综合征认知障碍的指标:对监测和康复的启示
Eur Arch Psychiatry Clin Neurosci. 2025 Sep 12. doi: 10.1007/s00406-025-02116-7.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Occupational therapy for cognitive impairment in stroke patients.脑卒中患者认知障碍的作业治疗。
Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD006430. doi: 10.1002/14651858.CD006430.pub3.
5
Multidisciplinary collaborative guidance on the assessment and treatment of patients with Long COVID: A compendium statement.关于长新冠患者评估与治疗的多学科协作指南:一份概要声明
PM R. 2025 Apr 22. doi: 10.1002/pmrj.13397.
6
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
7
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
8
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease.一年的练习效果可预测帕金森病的长期认知结果。
J Parkinsons Dis. 2025 Apr 29:1877718X251339585. doi: 10.1177/1877718X251339585.
9
Assessment of the relationship between hematologic parameters, (CPD), in screening for COVID-19 severity in women.评估血液学参数(CPD)与女性新冠病毒疾病严重程度筛查之间的关系。
Future Sci OA. 2025 Dec;11(1):2540749. doi: 10.1080/20565623.2025.2540749. Epub 2025 Aug 2.
10
Multi-domain interventions for the prevention of dementia and cognitive decline.多领域干预措施预防痴呆和认知能力下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2.

本文引用的文献

1
Long COVID: major findings, mechanisms and recommendations.长新冠:主要发现、机制和建议。
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
2
Olfactory-related quality of life impacts psychological distress in people with COVID-19: The affective implications of olfactory dysfunctions.COVID-19 患者嗅觉相关生活质量影响心理困扰:嗅觉功能障碍的情感影响。
J Affect Disord. 2023 Feb 15;323:741-747. doi: 10.1016/j.jad.2022.12.049. Epub 2022 Dec 15.
3
Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?
新冠后遗症和慢性疲劳综合征的脑雾,是同一种医学疾病吗?
J Transl Med. 2022 Dec 6;20(1):569. doi: 10.1186/s12967-022-03764-2.
4
COVID-19 and olfactory dysfunction: a looming wave of dementia?COVID-19 与嗅觉功能障碍:即将到来的痴呆浪潮?
J Neurophysiol. 2022 Aug 1;128(2):436-444. doi: 10.1152/jn.00255.2022. Epub 2022 Jul 27.
5
Association between chemosensory impairment with neuropsychiatric morbidity in post-acute COVID-19 syndrome: results from a multidisciplinary cohort study.新冠病毒感染后综合征患者的化学感觉障碍与神经精神发病之间的关联:一项多学科队列研究的结果。
Eur Arch Psychiatry Clin Neurosci. 2023 Mar;273(2):325-333. doi: 10.1007/s00406-022-01427-3. Epub 2022 May 28.
6
Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review.全球新型冠状病毒病 2019(COVID-19)后状况或长新冠的流行率:一项荟萃分析和系统评价。
J Infect Dis. 2022 Nov 1;226(9):1593-1607. doi: 10.1093/infdis/jiac136.
7
Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study.与 COVID-19 相关的认知功能障碍:一项全面的神经心理学研究。
J Psychiatr Res. 2022 Jun;150:40-46. doi: 10.1016/j.jpsychires.2022.03.033. Epub 2022 Mar 24.
8
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study.COVID-19 幸存者的认知、EEG 和 MRI 特征:一项 10 个月的研究。
J Neurol. 2022 Jul;269(7):3400-3412. doi: 10.1007/s00415-022-11047-5. Epub 2022 Mar 6.
9
Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort.新冠后大量挪威队列中过度风险和症状簇。
Eur J Epidemiol. 2022 May;37(5):539-548. doi: 10.1007/s10654-022-00847-8. Epub 2022 Feb 25.
10
Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis.COVID-19 后症状在住院和非住院 COVID-19 幸存者中的流行情况:系统评价和荟萃分析。
Eur J Intern Med. 2021 Oct;92:55-70. doi: 10.1016/j.ejim.2021.06.009. Epub 2021 Jun 16.